NCT03019783View on ClinicalTrials.gov

Atazanavir and Endothelial Function in Older HIV Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2016

Conditions
HIV
Interventions
DRUG

Atazanavir

The active group will switch from a non-atazanavir regimen to an atazanavir-based regimen.

OTHER

Placebo

The control group will stay on their baseline regimen

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT03019783 - Atazanavir and Endothelial Function in Older HIV Patients | Biotech Hunter | Biotech Hunter